Patents by Inventor Kees Fluiter

Kees Fluiter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT ANTAGONISTS AND USES THEREOF
    Publication number: 20150211003
    Abstract: Disclosed are antagonists designed to inhibit or block expression of a mammalian complement such as complement component 6 (C6). The invention has a wide range of uses including use in the preparation of a medicament for the enhancement of nerve regeneration following acute or chronic nerve damage in a mammal. Additional applications include use in the treatment of multiple sclerosis either alone or in combination with another drug.
    Type: Application
    Filed: March 12, 2014
    Publication date: July 30, 2015
    Applicant: REGENESANCE B.V.
    Inventors: Frank BAAS, Kees FLUITER
  • Complement antagonists and uses thereof
    Patent number: 9089555
    Abstract: Disclosed are antagonists designed to inhibit or block expression of a mammalian complement such as complement component 6 (C6). The invention has a wide range of uses including use in the preparation of a medicament for the enhancement of nerve regeneration following acute or chronic nerve damage in a mammal. Additional applications include use in the treatment of multiple sclerosis either alone or in combination with another drug.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: July 28, 2015
    Assignee: Regenesance B.V.
    Inventors: Frank Baas, Kees Fluiter
  • COMPLEMENT ANTAGONISTS AND USES THEREOF
    Publication number: 20140301982
    Abstract: Disclosed are antagonists designed to inhibit or block expression of a mammalian complement such as complement component 6 (C6). The invention has a wide range of uses including use in the preparation of a medicament for the enhancement of nerve regeneration following acute or chronic nerve damage in a mammal. Additional applications include use in the treatment of multiple sclerosis either alone or in combination with another drug.
    Type: Application
    Filed: March 12, 2014
    Publication date: October 9, 2014
    Applicant: REGENESANCE B.V.
    Inventors: Frank BAAS, Kees FLUITER
  • Complement antagonists and uses thereof
    Patent number: 8703730
    Abstract: Disclosed are antagonists designed to inhibit or block expression of a mammalian complement such as complement component 6 (C6). The invention has a wide range of uses including use in the preparation of a medicament for the enhancement of nerve regeneration following acute or chronic nerve damage in a mammal. Additional applications include use in the treatment of multiple sclerosis either alone or in combination with another drug.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: April 22, 2014
    Assignee: Regenesance B.V.
    Inventors: Frank Baas, Kees Fluiter
  • COMPLEMENT ANTAGONISTS AND USES THEREOF
    Publication number: 20110171176
    Abstract: Disclosed are antagonists designed to inhibit or block expression of a mammalian complement such as complement component 6 (C6). The invention has a wide range of uses including use in the preparation of a medicament for the enhancement of nerve regeneration following acute or chronic nerve damage in a mammal. Additional applications include use in the treatment of multiple sclerosis either alone or in combination with another drug.
    Type: Application
    Filed: July 10, 2009
    Publication date: July 14, 2011
    Applicant: Academisch Ziekenhuis Bij de Universiteit Van Amsterdam
    Inventors: Frank Baas, Kees Fluiter